Cellmid Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cellmid Limited with three other
companies in this sector in Australia:
sales of 4.54 million Australian Dollars [US$3.12 million]
of which 100%
was Health technologies),
(4.03 million Australian Dollars [US$2.77 million]
of which 176%
was Contract Services), and
(6.03 million Australian Dollars [US$4.14 million]
of which 93%
was Cancer Immunotherapy).
Cellmid Limited reported sales of A$7.47 million (US$5.12 million)
June of 2019.
increase of 29.6%
versus 2018, when the company's sales were A$5.76 million.
This was the fourth straight year of sales growth at Cellmid Limited.